名臣健康(002919.SZ)董事會同意成立網遊事業部
格隆匯 9 月 29日丨 名臣健康(002919.SZ)公佈,公司第二屆董事會第十四次會議決議,審議通過《關於成立網遊事業部的議案》
公司已於近期收購海南華多網絡科技有限公司(“海南華多”)、杭州雷焰網絡科技有限公司(“杭州雷焰”)且海南華多、杭州雷焰已成為公司的全資子公司,為了適應公司雙主業發展戰略,便於公司對遊戲板塊進行系統對接管理及規範運作,結合公司整體發展規劃,公司董事會同意成立網遊事業部。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.